Lilach Abramovitz

1.3k citations
13 papers · 967 indexed · h-index 11
Topics
Extracellular vesicles in disease (3 papers)Genetic Syndromes and Imprinting (2 papers)RNA Interference and Gene Delivery (2 papers)

In The Last Decade

Lilach Abramovitz

13 papers receiving 963 citations

Peers

Lilach Abramovitz
Comparison fields: 5 of 88
  • Molecular Biology 452
  • Oncology 376
  • Immunology 245
  • Cancer Research 165
  • Genetics 134
Replace Darren Finlay with:
Darren Finlay United States
Francine Grondin Canada
Hiroaki Kobayashi Japan
Min-Zu Wu United States
Sonali P. Barwe United States
Isabelle Galy–Fauroux France
Atsuhiko Kato Japan
Natalie Rittenhouse United States
Inmoo Rhee South Korea
Sandy Azzi France
Lilach Abramovitz relative to Darren Finlay United States Darren Finlay's profile →
Citations per field
00.5×1.5×
Darren Finlay · 1×
Citations per year

Countries citing papers authored by Lilach Abramovitz

Since Specialization
Citations

This map shows the geographic impact of Lilach Abramovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilach Abramovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilach Abramovitz more than expected).

Fields of papers citing papers by Lilach Abramovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilach Abramovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilach Abramovitz. The network helps show where Lilach Abramovitz may publish in the future.

Co-authorship network of co-authors of Lilach Abramovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Lilach Abramovitz. A scholar is included among the top collaborators of Lilach Abramovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilach Abramovitz. Lilach Abramovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 4
2 55
3 67
4 200
5 5
6 226
7 68
8 93
9 107
10 40
11 36
12 34
13 32

About Lilach Abramovitz

Lilach Abramovitz is a scholar working on Nephrology, Immunology and Pharmaceutical Science, having authored 13 papers that have together received 967 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (3 papers), Genetic Syndromes and Imprinting (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Nephrology (121 citations), Oncology (376 citations) and Immunology (245 citations). Lilach Abramovitz has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Neta Erez, Noam Cohen, Ophir Shani, Yael Raz, Yoray Sharon, Meir Goldsmith, Daniel Hoffman, Dan Peer, Rachel E. Bell and Sergey V. Novitskiy. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026